|
SSR4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.422100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.773500E-04 |
| Normal-vs-Stage2 |
4.200100E-02 |
| Normal-vs-Stage3 |
9.763900E-02 |
| Normal-vs-Stage4 |
6.049400E-01 |
| Stage1-vs-Stage2 |
8.639000E-01 |
| Stage1-vs-Stage3 |
1.700040E-01 |
| Stage1-vs-Stage4 |
3.318700E-03 |
| Stage2-vs-Stage3 |
4.534800E-01 |
| Stage2-vs-Stage4 |
9.014300E-02 |
| Stage3-vs-Stage4 |
2.258800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.502600E-03 |
| Normal-vs-AfricanAmerican |
4.668000E-01 |
| Normal-vs-Asian |
1.213190E-01 |
| Caucasian-vs-AfricanAmerican |
3.843200E-01 |
| Caucasian-vs-Asian |
9.482200E-01 |
| AfricanAmerican-vs-Asian |
4.509000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.556000E-02 |
| Normal-vs-Female |
3.378800E-03 |
| Male-vs-Female |
6.828200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.525000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.372460E-02 |
| Normal-vs-Age(61-80Yrs) |
1.067640E-01 |
| Normal-vs-Age(81-100Yrs) |
8.495300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.858000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.149000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.308000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.108200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.821800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.596230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.266800E-01 |
| Classical-VS-Follicular |
7.648000E-02 |
| Classical-VS-Other |
6.065400E-01 |
| Classical-VS-Normal |
1.880610E-01 |
| Tall-VS-Follicular |
2.898400E-01 |
| Tall-VS-Other |
9.646600E-01 |
| Tall-VS-Normal |
6.529600E-01 |
| Follicular-VS-Other |
3.381000E-01 |
| Follicular-VS-Normal |
1.366300E-02 |
| Other-VS-Normal |
6.527400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.624000E-04 |
| Normal-vs-N1 |
9.022400E-02 |
| N0-vs-N1 |
2.776600E-01 |
|
|
